Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations
Y Zheng, Z Xie, J Li, C Chen, W Cai, Y Dong… - BMC cardiovascular …, 2021 - Springer
Background Recent studies have reported the effects of metabolic syndrome (MetS) and its
components on atrial fibrillation (AF), but the results remain controversial. Therefore, we …
components on atrial fibrillation (AF), but the results remain controversial. Therefore, we …
Direct oral anticoagulants in obesity: an updated literature review
J Sebaaly, D Kelley - Annals of Pharmacotherapy, 2020 - journals.sagepub.com
Objective: To review literature on the use of direct-acting oral anticoagulants (DOACs) in
patients with high body weight (BW) and/or high body mass index (BMI) and to make …
patients with high body weight (BW) and/or high body mass index (BMI) and to make …
Comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants in atrial fibrillation patients
W Zhu, Z Ye, S Chen, D Wu, J He, Y Dong, GYH Lip… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: Several observational studies have compared the effect of the
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
Outcomes of direct oral anticoagulants in atrial fibrillation patients across different body mass index categories
Objectives This study sought to evaluate direct oral anticoagulant (DOAC) outcomes (vs.
warfarin) in patients with atrial fibrillation (AF) across body mass index (BMI) categories …
warfarin) in patients with atrial fibrillation (AF) across body mass index (BMI) categories …
Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease
X Cai, J Li, W Cai, C Chen, J Ma, Z Xie, Y Dong… - Journal of Diabetes and …, 2021 - Elsevier
Background Individuals with diabetes have a high risk of cardiovascular disease (CVD).
However, the association between type 1 diabetes mellitus (T1DM) and the risk of CVD has …
However, the association between type 1 diabetes mellitus (T1DM) and the risk of CVD has …
Stroke and bleeding risk assessments in patients with atrial fibrillation: concepts and controversies
Risk assessments are an important element in the management of patients with atrial
fibrillation (AF). In this review, we aim to discuss the concepts and controversies surrounding …
fibrillation (AF). In this review, we aim to discuss the concepts and controversies surrounding …
Impact of obesity on atrial fibrillation pathogenesis and treatment options
R Sha, O Baines, A Hayes, K Tompkins… - Journal of the …, 2024 - Am Heart Assoc
Atrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke,
heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both …
heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both …
Apixaban use in obese patients: a review of the pharmacokinetic, interventional, and observational study data
MJ Jamieson, W Byon, RW Dettloff, M Crawford… - American Journal of …, 2022 - Springer
Relatively little is known about the influence of extreme body weight on the
pharmacokinetics (PK), pharmacodynamics (PD), efficacy, and safety of drugs used in many …
pharmacokinetics (PK), pharmacodynamics (PD), efficacy, and safety of drugs used in many …
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m2
CP O'Kane, JCO Avalon, JL Lacoste… - … : The Journal of …, 2022 - Wiley Online Library
Background Apixaban and rivaroxaban are increasingly used for thromboembolism
prophylaxis in patients with non‐valvular atrial fibrillation (NVAF) and commonly in patients …
prophylaxis in patients with non‐valvular atrial fibrillation (NVAF) and commonly in patients …
Direct oral anticoagulants vs. Vitamin K antagonists in atrial fibrillation patients at risk of falling: a meta-analysis
X Gao, D Huang, Y Hu, Y Chen, H Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Direct oral anticoagulants (DOACs) and warfarin are usually used for people
with atrial fibrillation (AF). However, for the AF patients at risk of falling, the effectiveness and …
with atrial fibrillation (AF). However, for the AF patients at risk of falling, the effectiveness and …